Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves’ disease

References

• Adams, D. D. 1980. Thyroid-stimulating autoantibodies. Vitam. Horm. 38: 119–203
   PubMedGoogle Scholar
• McIver, B., and J. C. Morris. 1998. The pathogenesis of Graves' disease. Endocrinol. Metab. Clin. North. Am. 27: 73–89
   PubMed Web of Science ®Google Scholar
• Ayadi, H., H. Hadj Kacem, A. Rebai, and N. R. Farid. 2004. The genetics of autoimmune thyroid disease. Trends. Endocrinol. Metab. 15: 234–239
   PubMed Web of Science ®Google Scholar
• Tomer, Y. 2010. Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid. 20: 715–725
   PubMed Web of Science ®Google Scholar
• Hasham, A., and Y. Tomer. 2012. Genetic and epigenetic mechanisms in thyroid autoimmunity. Immunol. Res. 54: 204–213
   PubMed Web of Science ®Google Scholar
• Bossowski, A., H. Borysewicz-Sanczyk, N. Wawrusiewicz-Kurylonek, et al. 2014. Analysis of chosen polymorphisms in FoxP3 gene in children and adolescents with autoimmune thyroid diseases. Autoimmunity [Epub ahead of print]. doi: 10.3109/08916934.2014.910767
   Google Scholar
• Chu, X., C. M. Pan, S. X. Zhao, et al. 2011. A genome-wide association study identifies two new risk loci for Graves' disease. Nat. Genet. 43: 897–901
   PubMed Web of Science ®Google Scholar
• Ban, Y., T. Tozaki, and M. Taniyama. 2013. The replication of the association of the rs9355610 within 6p27 with Graves' disease. Autoimmunity. 46: 395–398
   PubMed Web of Science ®Google Scholar
• Morita, M., M. Watanabe, N. Inoue, et al. 2012. Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease. Autoimmunity. 45: 129–136
   PubMed Web of Science ®Google Scholar
• Yang, Y., X. Su, K. Zhang, and R. Zhou. 2013. The Fc receptor-like 3 gene polymorphisms and susceptibility to autoimmune diseases: an updated meta-analysis. Autoimmunity. 46: 547–558
   PubMed Web of Science ®Google Scholar
• Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675–680
   PubMed Web of Science ®Google Scholar
• Chang, Z. L. 2010. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm. Res. 59: 791–808
   PubMed Web of Science ®Google Scholar
• Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell. 124: 783–801
   PubMed Web of Science ®Google Scholar
• Chuang, T., and R. J. Ulevitch. 2001. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta. 1518: 157–161
   PubMed Web of Science ®Google Scholar
• Guan, Y., D. R. Ranoa, S. Jiang, et al. 2010. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J. Immunol. 184: 5094–5103
   Google Scholar
• Veltkamp, M., C. H. van Moorsel, G. T. Rijkers, et al. 2012. Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis. Tissue. Antigens. 79: 25–32
   PubMedGoogle Scholar
• Stevens, V. L., A. W. Hsing, J. T. Talbot, et al. 2008. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int. J. Cancer. 123: 2644–2650
   PubMed Web of Science ®Google Scholar
• Requena, T., I. Gazquez, A. Moreno, et al. 2013. Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease. Immunogenetic. 65: 345–355
   PubMed Web of Science ®Google Scholar
• Misch, E. A., A. Verbon, J. M. Prins, et al. 2013. A TLR6 polymorphism is associated with increased risk of Legionnaires' disease. Genes Immun. 14: 420–426
   PubMed Web of Science ®Google Scholar
• Morgan, A. R., W. J. Lam, D. Y. Han, et al. 2012. Genetic variation within TLR10 is associated with Crohn's disease in a New Zealand population. Hum. Immunol. 73: 416–420
   PubMed Web of Science ®Google Scholar
• Thompson, C. M., T. D. Holden, G. Rona, et al. 2014. Toll-like receptor 1 polymorphisms and associated outcomes in sepsis after traumatic injury: a candidate gene association study. Ann. Surg. 259: 179–185
   PubMed Web of Science ®Google Scholar
• Eschler, D. C., A. Hasham, and Y. Tomer. 2011. Cutting edge: the etiology of autoimmune thyroid diseases. Clin. Rev. Aller. Immunol. 41: 190–197
   PubMed Web of Science ®Google Scholar
• Hargreaves, C. E., M. Grasso, C. S. Hampe, et al. 2013. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves' disease. J. Immunol. 190: 5373–5381
   PubMed Web of Science ®Google Scholar
• Figura, N., G. Di Cairano, F. Lore, et al. 1999. The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J. Physiol. Pharmacol. 50: 817–826
   PubMed Web of Science ®Google Scholar
• Benvenga, S., F. Guarneri, M. Vaccaro, et al. 2004. Homologies between proteins of Borrelia burgdorferi and thyroid autoantigens. Thyroid. 14: 964–966
   PubMed Web of Science ®Google Scholar
• Jaspan, J. B., H. Luo, B. Ahmed, et al. 1995. Evidence for a retroviral trigger in Graves' disease. Autoimmunity. 20: 135–142
   PubMed Web of Science ®Google Scholar
• Menconi, F., A. Hasham, and Y. Tomer. 2011. Environmental triggers of thyroiditis: hepatitis C and interferon-alpha. J. Endocrinol. Invest. 34: 78–84
   PubMed Web of Science ®Google Scholar
• Caturegli, P., H. Kimura, R. Rocchi, and N. R. Rose. 2007. Autoimmune thyroid diseases. Curr. Opin. Rheumatol. 19: 44–48
   PubMed Web of Science ®Google Scholar
• Harii, N., C. J. Lewis, V. Vasko, et al. 2005. Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis. Mol. Endocrinol. 19: 1231–1250
   PubMedGoogle Scholar
• Kawashima, A., K. Yamazaki, T. Hara, et al. 2013. Demonstration of innate immune responses in the thyroid gland: potential to sense danger and a possible trigger for autoimmune reactions. Thyroid. 23: 477–487
   PubMed Web of Science ®Google Scholar
• Nicola, J. P., M. L. Velez, A. M. Lucero, et al. 2009. Functional toll-like receptor 4 conferring lipopolysaccharide responsiveness is expressed in thyroid cells. Endocrinology. 150: 500–508
   PubMed Web of Science ®Google Scholar
• Finke, D., M. L. Eloranta, and L. Ronnblom. 2009. Endogenous type I interferon inducers in autoimmune diseases. Autoimmunity. 42: 349–352
   PubMed Web of Science ®Google Scholar
• Yan, N., Y. L. Yu, J. Yang, et al. 2012. Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity. 45: 533–539
   PubMed Web of Science ®Google Scholar
• Molnar, I.2007. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy. Autoimmunity. 40: 31–37
   PubMed Web of Science ®Google Scholar
• Liao, W.-L., R.-H. Chen, H.-J. Lin, et al. 2010. Toll-like receptor gene polymorphisms are associated with susceptibility to graves' ophthalmopathy in Taiwan males. BMC Med. Genet. 11: 154
   PubMed Web of Science ®Google Scholar
• Carlson, C., M. Eberle, M. Rieder, et al. 2004. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74: 106–120
   PubMed Web of Science ®Google Scholar
• Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21: 263–265
   PubMed Web of Science ®Google Scholar
• Stephens, M., N. J. Smith, and P. Donnelly. 2001. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68: 978–989
   PubMed Web of Science ®Google Scholar
• Stephens, M., and P. Scheet. 2005. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am. J. Hum. Genet. 76: 449–462
   PubMed Web of Science ®Google Scholar
• Hamann, L., C. Glaeser, A. Hamprecht, et al. 2006. Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin. Chim. Acta. 364: 303–307
   PubMed Web of Science ®Google Scholar
• Wang, Y. L., M. S. Tan, J. T. Yu, et al. 2013. Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer's disease in Han Chinese. J. Neuroinflammation. 10: 101–105
   PubMed Web of Science ®Google Scholar
• Zhang, J., Q. Zhu, F. Meng, et al. 2014. Association study of TLR-9 polymorphisms and systemic lupus erythematosus in northern Chinese Han population. Gene. 533: 385–388
   PubMed Web of Science ®Google Scholar
• Perros, P., A. L. Crombie, J. N. Matthews, and P. Kendall-Taylor. 1993. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin. Endocrinol (Oxf). 38: 367–372
   PubMed Web of Science ®Google Scholar
• Yamada, T., T. Aizawa, Y. Koizumi, et al. 1994. Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease. J. Am. Geriatr. Soc. 42: 513–516
   PubMed Web of Science ®Google Scholar
• Allahabadia, A., J. Daykin, R. L. Holder, et al. 2000. Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J. Clin. Endocrinol. Metab. 85: 1038–1042
   PubMed Web of Science ®Google Scholar
• Melcescu, E., W. B. Horton, D. Kim, et al. 2014. Graves orbitopathy: update on diagnosis and therapy. South. Med. J. 107: 34–43
   PubMed Web of Science ®Google Scholar
• Paavonen, T. 1994. Hormonal regulation of immune responses. Ann. Med. 26: 255–258
   PubMed Web of Science ®Google Scholar
• Da Silva, J. A. 1995. Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses. Ann. Rheum. Dis. 54: 6–16
   PubMed Web of Science ®Google Scholar